More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$271867873
EPS
-1.11
P/E ratio
--
Price to sales
0.45
Dividend yield
--
Beta
0.661044
Previous close
$6.80
Today's open
$6.71
Day's range
$6.62 - $6.91
52 week range
$6.52 - $16.42
show more
CEO
Massimo Calafiore
Employees
1605
Headquarters
Lewisville, TX
Exchange
Nasdaq Global Select
Shares outstanding
40759801
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
Orthofix (OFIX) Upgraded to Buy: What Does It Mean for the Stock?
Orthofix (OFIX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks Investment Research • 4 hours ago

Orthofix Medical Q3 Earnings Call Highlights
Orthofix Medical NASDAQ: OFIX lowered its 2026 outlook after third-quarter results fell short of management's expectations, as softer U.S. spine procedure volumes and supplier delays constrained its ability to support demand.
MarketBeat • Nov 9, 2026

Orthofix Medical Inc. (OFIX) Q3 2026 Earnings Call Transcript
Orthofix Medical Inc. (OFIX) Q3 2026 Earnings Call Transcript
Seeking Alpha • Nov 9, 2026

Orthofix Reports Third Quarter 2026 Results and Revises Full-Year 2026 Guidance
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported financial results for the third quarter ended September 30, 2026, and revised its full-year 2026 net sales and non-GAAP adjusted EBITDA guidance. Unless otherwise noted, pro forma results exclude the impact of the discontinued M6™ product lines. Third Quarter 2026 Highlights Total reported net sales of $207.9 million, representing an increase of 1% on a reported b.
Business Wire • Nov 9, 2026

Orthofix (OFIX) Surpasses Q3 Earnings Estimates
Orthofix (OFIX) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.2 per share a year ago.
Zacks Investment Research • Nov 9, 2026

Orthofix (OFIX) Surges 11.0%: Is This an Indication of Further Gains?
Orthofix (OFIX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks Investment Research • Nov 5, 2026

Orthofix to Report Third Quarter 2026 Financial Results
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its third quarter 2026 financial results on Monday, November 9, 2026, before market open. The Company will host a conference call and webcast to review results at 8:30 am Eastern Time the same day. Interested parties may access the conference call by dialing 833-461-5787 in the U.S., and 585-542-9983 in all other locations, and referencing th.
Business Wire • Oct 23, 2026

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of Orthofix Medical Inc. (NASDAQ: OFIX)
NEW YORK, Oct. 21, 2026 /PRNewswire/ -- Levi & Korsinsky announces that it has commenced an investigation of Orthofix Medical Inc. (NASDAQ: OFIX) concerning possible breaches of fiduciary duties. If you are a current shareholder of OFIX, you can request additional information here: https://zlk.com/cases/orthofix-medical-inc-class-action-lawsuit-ofix-2 or contact Joseph E.
PRNewsWire • Oct 21, 2026

Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
PRNewsWire • Oct 13, 2026

Orthofix Medical Sees Reimbursement Rebound, but Spine Slump Clouds Outlook
Orthofix Medical NASDAQ: OFIX executives said the company's updated outlook reflects the restoration of bone growth stimulation reimbursement, improving trends in biologics and limb reconstruction, and an expected European inventory order, partly offset by a steeper-than-anticipated decline among smaller U.S. spine distributors.
MarketBeat • Aug 16, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Orthofix Medical Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.